Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Belgium-based Ablynx has received a Certificate of Good Laboratory Practise (GLP) from the Belgian Scientific Institute of Public Health (IPH) for its new GLP unit established in Ghent, Belgium.
Subscribe to our email newsletter
The granting of certificate follows a proper inspection conducted by the Belgian authorities in May 2011.
With this certification, Ablynx is now eligible to conduct preclinical testing and pharmacokinetics studies in-house, to the required regulatory standard.
Ablynx chairman and CEO Edwin Moses said with this certificate, they no longer solely rely on third parties to carry out the pre-clinical GLP testing for their programmes.
"This enables us to retain more control on quality, timing and associated costs," Moses said.